Histone deacetylase inhibitors require caspase activity to induce apoptosis in lung and prostate carcinoma cells. (Record no. 16071395)

MARC details
000 -LEADER
fixed length control field 01391 a2200385 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250515014202.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 200604s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 0304-3835
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1016/j.canlet.2005.02.009
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Sonnemann, Jürgen
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 20060406
245 00 - TITLE STATEMENT
Title Histone deacetylase inhibitors require caspase activity to induce apoptosis in lung and prostate carcinoma cells.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. Cancer letters
Date of publication, distribution, etc. Feb 2006
300 ## - PHYSICAL DESCRIPTION
Extent 148-60 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Journal Article; Research Support, Non-U.S. Gov't
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Amino Acid Chloromethyl Ketones
General subdivision pharmacology
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Apoptosis
General subdivision drug effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Caspases
General subdivision physiology
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Cell Line, Tumor
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element DNA Fragmentation
General subdivision drug effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Enzyme Inhibitors
General subdivision pharmacology
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Histone Deacetylase Inhibitors
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Lung Neoplasms
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Male
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Prostatic Neoplasms
General subdivision drug therapy
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Hartwig, Maite
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Plath, Andrea
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Saravana Kumar, K
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Müller, Cornelia
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Beck, James F
773 0# - HOST ITEM ENTRY
Title Cancer letters
Related parts vol. 232
-- no. 2
-- p. 148-60
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1016/j.canlet.2005.02.009">https://doi.org/10.1016/j.canlet.2005.02.009</a>
Public note Available from publisher's website

No items available.